Si-Bone Inc Cash Flow Conversion Efficiency

Latest as of June 2026: 0.004x

Si-Bone Inc cash flow conversion efficiency. Based on the latest financial reports, Si-Bone Inc (SIBN) has a cash flow conversion efficiency ratio of 0.004x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($777.00K) by net assets ($182.35 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Si-Bone Inc (2013–2025)

Cash flow conversion efficiency of Si-Bone Inc from 2013 to 2025. This chart illustrates how Si-Bone Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View SIBN stock price for real-time trading data and today's change.

Si-Bone Inc Cash Flow Conversion Ratio Explained

Si-Bone Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Si-Bone Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Si-Bone Inc ranked by their cash flow conversion efficiency. Also see market cap of Si-Bone Inc for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
China West Construction Group Co Ltd
SHE:002302
-0.013x
Guangdong Shaoneng Group Co Ltd
SHE:000601
0.095x
Kri-Kri Milk Industry S.A
AT:KRI
0.059x
Festi hf
IC:FESTI
-0.001x
Dashang Co Ltd
SHG:600694
0.006x
SUFA Technology Industry Co Ltd CNNC
SHE:000777
0.002x
SpyGlass Pharma, Inc.
NASDAQ:SGP
-0.064x
Logwin AG
XETRA:TGHN
0.123x

Annual Cash Flow Conversion Efficiency for Si-Bone Inc (2013–2025)

The table below shows the annual cash flow conversion efficiency of Si-Bone Inc from 2013 to 2025. Review SIBN free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $177.53 Million $-675.00K -0.004x +94.89%
2024-12-31 $166.96 Million $-12.43 Million -0.074x +32.64%
2023-12-31 $169.38 Million $-18.71 Million -0.110x +73.93%
2022-12-31 $98.30 Million $-41.66 Million -0.424x -44.08%
2021-12-31 $134.42 Million $-39.53 Million -0.294x -62.45%
2020-12-31 $169.36 Million $-30.66 Million -0.181x +63.93%
2019-12-31 $63.01 Million $-31.63 Million -0.502x -211.81%
2018-12-31 $90.19 Million $-14.52 Million -0.161x -218.81%
2017-12-31 $-129.38 Million $-17.53 Million 0.135x -12.06%
2016-12-31 $-108.73 Million $-16.75 Million 0.154x +101.86%
2015-12-31 $3.23 Million $-26.72 Million -8.264x -116.34%
2014-12-31 $6.89 Million $-26.33 Million -3.820x -1215.61%
2013-12-31 $-1.65 Million $-566.00K 0.342x --

About Si-Bone Inc

NASDAQ:SIBN USA Medical Devices
Market Cap
$1.07 Billion
Market Cap Rank
#9392 Global
#2639 in USA
Share Price
$23.77
Change (1 day)
+17.56%
52-Week Range
$11.61 - $23.77
All Time High
$35.96
About

SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium … Read more